Skip to content

Efficacy and Safety of Soriclear, Congnitive Behavioral Therapy, Tones Stimulator in patients with Subjective Tinnitus: Prospective, Multi-center

Efficacy and Safety of Soriclear, Congnitive Behavioral Therapy, Tones Stimulator in patients with Subjective Tinnitus: Prospective, Multi-center

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011314
Enrollment
292
Registered
2025-12-11
Start date
2024-01-18
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Participants in the SoriClear group are instructed to engage in SoriClear’s personalized internet-based cognitive behavioral therapy (iCBT), complete thought records, and receive soun

Sponsors

Yonsei University Health System, Severance Hospital
Lead Sponsor
The Catholic University of Korea, Seoul St. Mary's Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Male or female participants aged 19 years or older 2) Individuals with confirmed chronic tinnitus lasting for more than 3 months 3) Individuals with pure-tone air conduction hearing thresholds of 60 dB HL or lower (based on the 6-division method) 4) Individuals with a Tinnitus Handicap Inventory (THI) score of 18 or higher 5) Individuals capable of using the internet and mobile applications 6) Individuals who have understood the nature of the clinical trial and voluntarily signed the informed consent form

Exclusion criteria

Exclusion criteria: 1) Individuals diagnosed with objective tinnitus (e.g., pulsatile or muscular tinnitus) 2) Individuals whose tinnitus is confirmed to be caused by middle ear infection, inner ear infection, or Eustachian tube disorder 3) Individuals diagnosed with any other primary neurodegenerative dementia, schizophrenia, or bipolar disorder, or any other DSM-V Axis I disorder, excluding depression 4) Individuals deemed unsuitable for participation in this clinical trial by the principal investigator 5) Individuals currently participating in another clinical trial or who have participated in another clinical trial within one month prior to the screening date

Design outcomes

Primary

MeasureTime frame
Total Tinnitus Handicap Inventory score change

Secondary

MeasureTime frame
Total Tinnitus Functional Index score change;Change in tinnitus pitch and loudness matching;Change in Visual analog scale (Emotional Distress);Change in Visual analog scale (Cognitive Distress);Satisfaction questionnaire score

Countries

Korea, Republic of

Contacts

Public ContactSo-Young Park

The Catholic University of Korea, Seoul St. Mary's Hospital

miffy8624 @naver.com+82-2-2258-6210

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Jun 21, 2026